Health
New tool can provide non-invasive decision support for NSCLC treatment – News-Medical.net
Personalized treatment options for patients with lung cancer have come a long way in the past two decades.
Reviewed by Emily Henderson, B.Sc.Oct 16 2020
Personalized treatment options for patients with lung cancer have come a long way in the past two decades. For patients with non-small cell lung cancer, the most common subtype of lung cancer and the leading cause of cancer-related death worldwide, two major treatment strategies have emerged: tyrosine kinase inhibitors and immune checkpoint inhibitors. However, choosing the right therapy for a non-small cell lung cancer patient isn’t always an easy …
-
Noosa News19 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General19 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
Noosa News5 hours agoMotorcyclist dies in crash with truck
-
General21 hours agoPerth man charged after investigation into organised crime and tobacco store attacks